Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients

Clinical trial NCT06389682 · COMPLETED

Trial details

NCT number: NCT06389682
Sponsor: Norroy Bioscience Co., LTD
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Metastatic

Start date: 2024-06-17
Primary completion: 2025-01-08
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.